Image: Shutterstock/anyaivanova Image: Shutterstock/anyaivanova IRISH BIOTECH COMPANY Inflazome has been acquired by Swiss drug giant Roche for €380 million.
It is understood that they are also eligible to receive additional payments contingent on the achievement of certain milestones. Speaking on the Pat Kenny Show on Newstalk this morning, Professor O’Neill said, “Roche can now take our drug and bring it to the clinic, which is tremendously exciting. Founded in 2016, the company’s intellectual property is based on the Science Foundation Ireland-funded research of Professor O’Neill at Trinity College Dublin in partnership with the University of Queensland.
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más: